Fisher & Paykel Healthcare Corporation Limited
FSPKF · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | $17,451,284 | $15,052,584 | $14,063,029 | $13,526,741 |
| - Cash | $264,500 | $82,000 | $121,000 | $89,900 |
| + Debt | $153,300 | $189,100 | $145,800 | $104,300 |
| Enterprise Value | $17,340,084 | $15,159,684 | $14,087,829 | $13,541,141 |
| Revenue | $1,280,300 | $1,758,100 | $1,588,600 | $1,642,400 |
| % Growth | -27.2% | 10.7% | -3.3% | – |
| Gross Profit | $530,200 | $1,059,700 | $945,900 | $1,013,400 |
| % Margin | 41.4% | 60.3% | 59.5% | 61.7% |
| EBITDA | $654,300 | $368,200 | $433,700 | $605,100 |
| % Margin | 51.1% | 20.9% | 27.3% | 36.8% |
| Net Income | $377,200 | $132,600 | $250,300 | $376,900 |
| % Margin | 29.5% | 7.5% | 15.8% | 22.9% |
| EPS Diluted | 0.64 | 0.23 | 0.43 | 0.65 |
| % Growth | 178.3% | -46.5% | -33.8% | – |
| Operating Cash Flow | $548,600 | $429,600 | $238,200 | $324,300 |
| Capital Expenditures | -$103,000 | -$339,000 | -$211,300 | -$169,800 |
| Free Cash Flow | $445,600 | $90,600 | $26,900 | $154,500 |